Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Net Assets

Latest as of March 2026: CN¥6.24 Billion CNY ≈ $913.17 Million USD

Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has net assets worth CN¥6.24 Billion CNY (≈ $913.17 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.29 Billion ≈ $1.21 Billion USD) and total liabilities (CN¥2.05 Billion ≈ $299.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Yunnan Botanee Bio-Technology Group Co L to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥6.24 Billion
% of Total Assets 75.29%
Annual Growth Rate 48.79%
5-Year Change 31.94%
10-Year Change N/A
Growth Volatility 91.96

Yunnan Botanee Bio-Technology Group Co Ltd - Net Assets Trend (2017–2025)

This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's net assets have evolved over time, based on quarterly financial data. See Yunnan Botanee Bio-Technology Group Co L liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)

The table below shows the annual net assets of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. For live valuation and market cap data, see Yunnan Botanee Bio-Technology Group Co L (300957) total market value.

Year Net Assets Change
2025-12-31 CN¥6.30 Billion
≈ $922.55 Million
+1.89%
2024-12-31 CN¥6.19 Billion
≈ $905.47 Million
+2.86%
2023-12-31 CN¥6.02 Billion
≈ $880.30 Million
+7.38%
2022-12-31 CN¥5.60 Billion
≈ $819.80 Million
+17.24%
2021-12-31 CN¥4.78 Billion
≈ $699.24 Million
+297.60%
2020-12-31 CN¥1.20 Billion
≈ $175.86 Million
+57.92%
2019-12-31 CN¥761.02 Million
≈ $111.36 Million
+68.79%
2018-12-31 CN¥450.87 Million
≈ $65.98 Million
+71.80%
2017-12-31 CN¥262.44 Million
≈ $38.40 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Yunnan Botanee Bio-Technology Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1445.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥2.99 Billion 48.62%
Other Components CN¥3.16 Billion 51.38%
Total Equity CN¥6.16 Billion 100.00%

Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Market Cap

The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their market capitalization.

Company Market Cap
Netac Tech
SHE:300042
$2.06 Billion
Wankai New Materials Co. Ltd.
SHE:301216
$2.07 Billion
Zhejiang Semir Garment Co Ltd
SHE:002563
$2.07 Billion
Capri Holdings Ltd
NYSE:CPRI
$2.07 Billion
Northwest Natural Gas Co
NYSE:NWN
$2.06 Billion
Turpaz Industries Ltd
TA:TRPZ
$2.06 Billion
Bure Equity AB
ST:BURE
$2.06 Billion
Tibet Urban Development and Investment Co Ltd
SHG:600773
$2.06 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yunnan Botanee Bio-Technology Group Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 6,049,901,389 to 6,157,265,025, a change of 107,363,636 (1.8%).
  • Net income of 505,719,664 contributed positively to equity growth.
  • Dividend payments of 265,638,494 reduced retained earnings.
  • Other comprehensive income decreased equity by 229,344,663.
  • Other factors increased equity by 96,627,129.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥505.72 Million +8.21%
Dividends Paid CN¥265.64 Million -4.31%
Other Comprehensive Income CN¥-229.34 Million -3.72%
Other Changes CN¥96.63 Million +1.57%
Total Change CN¥- 1.77%

Book Value vs Market Value Analysis

This analysis compares Yunnan Botanee Bio-Technology Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.29x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 47.17x to 2.29x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 CN¥0.71 CN¥33.28 x
2018-12-31 CN¥1.23 CN¥33.28 x
2019-12-31 CN¥1.79 CN¥33.28 x
2020-12-31 CN¥2.83 CN¥33.28 x
2021-12-31 CN¥11.23 CN¥33.28 x
2022-12-31 CN¥13.11 CN¥33.28 x
2023-12-31 CN¥13.86 CN¥33.28 x
2024-12-31 CN¥14.43 CN¥33.28 x
2025-12-31 CN¥14.54 CN¥33.28 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yunnan Botanee Bio-Technology Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.21%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.44%
  • • Asset Turnover: 0.64x
  • • Equity Multiplier: 1.35x
  • Recent ROE (8.21%) is below the historical average (31.68%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 60.26% 19.25% 1.59x 1.97x CN¥128.14 Million
2018 58.53% 21.00% 1.62x 1.72x CN¥216.01 Million
2019 54.47% 21.19% 1.79x 1.43x CN¥336.32 Million
2020 45.33% 20.61% 1.57x 1.40x CN¥423.61 Million
2021 18.15% 21.45% 0.69x 1.22x CN¥387.40 Million
2022 18.93% 20.97% 0.75x 1.21x CN¥496.04 Million
2023 12.91% 13.21% 0.76x 1.28x CN¥170.70 Million
2024 8.32% 8.77% 0.69x 1.37x CN¥-101.94 Million
2025 8.21% 9.44% 0.64x 1.35x CN¥-110.01 Million

Industry Comparison

This section compares Yunnan Botanee Bio-Technology Group Co Ltd's net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

  • Industry: Household & Personal Products
  • Average net assets among peers: $1,396,525,528
  • Average return on equity (ROE) among peers: 6.82%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yunnan Botanee Bio-Technology Group Co Ltd (300957) CN¥6.24 Billion 60.26% 0.33x $2.06 Billion
Lonkey Industrial Co Ltd Guangzhou (000523) $390.93 Million 0.57% 0.45x $743.99 Million
Tianjin Yiyi Hygiene Products Co Ltd (001206) $273.92 Million 12.92% 0.78x $452.64 Million
Hunan Resun Co Ltd (001218) $2.21 Billion 4.95% 0.30x $469.75 Million
Qingdao Kingking Applied Chemistry Co Ltd (002094) $3.37 Billion 3.09% 0.75x $471.13 Million
C&S Paper Co Ltd (002511) $3.31 Billion 12.29% 0.55x $1.29 Billion
Anhui Deli Household Glass Co Ltd (002571) $1.47 Billion -4.17% 0.37x $622.30 Million
Mingchen Health Co Ltd Class A (002919) $550.90 Million 5.38% 0.27x $766.42 Million
Chongqing Baiya Sanitary Products Co (003006) $312.82 Million 21.45% 0.44x $931.12 Million
Chengdu Rainbow Appliance Gr (003023) $1.44 Billion 6.57% 0.37x $336.35 Million
Fujian Green Pine Co Ltd (300132) $634.58 Million 5.16% 0.13x $452.80 Million

About Yunnan Botanee Bio-Technology Group Co Ltd

SHE:300957 China Household & Personal Products
Market Cap
$2.06 Billion
CN¥14.10 Billion CNY
Market Cap Rank
#6228 Global
#1309 in China
Share Price
CN¥33.28
Change (1 day)
-0.89%
52-Week Range
CN¥32.58 - CN¥50.85
All Time High
CN¥277.86
About

Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more